Larimar Therapeutics (LRMR) Cash from Financing Activities (2013 - 2024)
Larimar Therapeutics (LRMR) recorded Cash from Financing Activities of $65.09 million in FY2025, down 59.8% from $161.88 million in FY2024.
Powered by 
Analysis
Larimar Therapeutics (LRMR) Cash from Financing Activities (2013 - 2024) Analysis & Trends
Starting with FY2012, Larimar Therapeutics' Cash from Financing Activities history includes 14 years.
- Annual Cash from Financing Activities has a five-year compound annual growth rate of -7.0% (FY2020 to FY2025).
- Annual Cash from Financing Activities has ranged from $30,000 in FY2023 to $161.88 million in FY2024 over the past five years.
- Per Business Quant data, LRMR's Cash from Financing Activities was $161.88 million in FY2024, $30,000 in FY2023 (-100.0%), $75.26 million in FY2022 (+278.5%) and $19.89 million in FY2021 (-78.8%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | -8.78 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | -5.05 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 1.76 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -2.02 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -47.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -1.48 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 2.34 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -3.66 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | -426.70 Mn |
| 10 | Larimar Therapeutics | 331.39 Mn | -275.69 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 36,000.00 |
| Sep 30, 2024 | 30,000.00 |
| Jun 30, 2024 | -334,000.00 |
| Mar 31, 2024 | 162.15 Mn |
| Dec 31, 2022 | -316,000.00 |
| Dec 31, 2020 | 242,000.00 |
| Sep 30, 2020 | -135,000.00 |
| Jun 30, 2020 | 83.90 Mn |
| Mar 31, 2020 | 9.58 Mn |
| Dec 31, 2019 | 3.46 Mn |
| Sep 30, 2019 | 9.95 Mn |
| Jun 30, 2019 | 5.90 Mn |
| Mar 31, 2019 | 95,000.00 |
| Dec 31, 2018 | 1.76 Mn |
| Sep 30, 2018 | 64.91 Mn |
| Jun 30, 2018 | -18,000.00 |
| Mar 31, 2018 | 261,000.00 |
| Dec 31, 2017 | 18.73 Mn |
| Sep 30, 2017 | -724,000.00 |
| Jun 30, 2017 | -712,000.00 |
API Access
Larimar Therapeutics Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=LRMR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "LRMR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=LRMR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();